Medical microbiology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS56
Academic Journal
Presents an abstract of the research manuscript `Risk reduction of mother-to-child HIV transmission by antiretroviral therapy in a clinical setting,' by N. Lapointe et al. Zidovudine treatment.


Related Articles

  • If you're positive, take AZT.  // Joe Weider's Muscle & Fitness;May95, Vol. 56 Issue 5, p48 

    Reports that AZT drug therapy can reduce the risk for mother-to-child HIV transmission. Legal and ethical concerns of AZT drug therapy.

  • Short-course zidovudine in perinatal HIV transmission.  // WHO Drug Information;1999, Vol. 13 Issue 1, p6 

    Reports on clinical trials of short-course zidovudine use in perinatal human immunodeficiency virus (HIV) transmission. Reduction of the risk of transmission; Need to identify HIV infected women who do not receive zidovudine during pregnancy.

  • DECLINE IN VERTICAL TRANSMISSION.  // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p615 

    Reports on the decline in the vertical transmission rates of HIV in the United States. Rate decline from 1990 to 1997; Role of the routine use of azidothymidine in HIV-infected pregnant women in the decline.

  • Short-course zidovudine in perinatal HIV transmission: more evidence and debate.  // WHO Drug Information;1999, Vol. 13 Issue 2, p65 

    Describes the use of short-course zidovudine in perinatal HIV transmission. Role of elective cesarean section in prevention of HIV transmission; Efficacy of zidovudine in breast-feeding women; Difficulties in HIV counselling and testing and drug management during labor.

  • An affordable HIV regimen. Althaus, Frances // International Family Planning Perspectives;Jun98, Vol. 24 Issue 2, p54 

    Reports on the use of the antiretroviral drug zidovudine for HIV-infected pregnant women to lower the rate of perinatal HIV transmission from mother to infant. Feasibility of the regimen for implementation in developing countries.

  • Successful Implementation of Perinatal HIV Prevention Guidelines. Wortley, Pascale M.; Lindegren, Mary Lou; Fleming, Patricia L. // MMWR: Morbidity & Mortality Weekly Report;5/11/2001Supplement RR-6, Vol. 50 Issue 18, p15 

    Presents information on a study which evaluated the implementation of guidelines regarding the use of zidovudine to reduce perinatal transmission of the human immunodeficiency virus. Methodology of the study; Results and discussion on the study; Conclusion.

  • Study shows Retrovir can prevent mother-to-infant HIV transmission.  // New York Amsterdam News;11/12/94, Vol. 85 Issue 46, p14 

    Reports on the preliminary results of a study on the treatment of HIV-infected women and their newborns with Retrovir. Reduction of the risk of maternal-to-fetal transmission of the virus; Food and Drug administration's approval of the drug for the indication; Study protocol.

  • Vertical transmission: Now preventable. Legg, Jill J.; Minkoff, Howard S. // Patient Care;5/15/1996, Vol. 30 Issue 9, p160 

    Reports that mother-to-infant transmission of AIDS is preventable with zidovudine therapy. AIDS in children in the United States as attributable to perinatal transmission of HIV; Maternal risk factors; Use of AZT.

  • Cost-Effective HIV Prevention. Althaus, Frances // International Family Planning Perspectives;Sep98, Vol. 24 Issue 3, p102 

    Reports on a cost-effective HIV prevention measure proposed for Sub-Saharan Africa. Prevention of perinatal transmission of the virus from mother to child through a short course of zidovudine given to pregnant, HIV-infected women; Cost analysis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics